Paper656379
Aminoglycoside antibiotics and eukaryotic protein synthesis: stimulation of errors in the translation of natural messengers in extracts of cultured human cells.
Wilhelm JM and 2 others. Biochemistry, 1978. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Aminoglycoside antibiotics and eukaryotic protein synthesis: stimulation of errors in the translation of natural messengers in extracts of cultured human cells. Papers, record 656379. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/656379
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Aminoglycoside antibiotics and eukaryotic protein synthesis: stimulation of errors in the translation of natural messengers in extracts of cultured human cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoglycosides | Major topic |
| Anti-Bacterial Agents | Major topic |
| Protein Biosynthesis | Major topic |
| RNA, Messenger | Major topic |
| Adenoviruses, Human | |
| Cell Line | |
| Cell-Free System | |
| Humans | |
| Leucine | |
| Paromomycin | |
| Poly U | |
| Viral Proteins |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,561,069 | Paromomycin is a more effective selection agent than kanamycin in Arabidopsis harboring the neomycin phosphotransferase II transgene. | PLoS One | 2025 | https://conductscience.org/library/papers/40561069 | PubMed |
| 37,379,072 | The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold? | Expert Opin Pharmacother | 2023 | https://conductscience.org/library/papers/37379072 | PubMed |
| 33,166,396 | The catalytic activity of the translation termination factor methyltransferase Mtq2-Trm112 complex is required for large ribosomal subunit biogenesis. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/33166396 | PubMed |
| 32,178,712 | Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. | Mol Neurodegener | 2020 | https://conductscience.org/library/papers/32178712 | PubMed |
| 30,050,367 | Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy. | Degener Neurol Neuromuscul Dis | 2016 | https://conductscience.org/library/papers/30050367 | PubMed |
| 29,208,708 | Aminoglycoside interactions and impacts on the eukaryotic ribosome. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/29208708 | PubMed |
| 28,367,323 | Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases. | Diseases | 2016 | https://conductscience.org/library/papers/28367323 | PubMed |
| 24,773,318 | Therapeutics based on stop codon readthrough. | Annu Rev Genomics Hum Genet | 2014 | https://conductscience.org/library/papers/24773318 | PubMed |
| 24,186,089 | Ribosomal control of translational fidelity in Podospora anserina: A suppressor and an antisuppressor affecting the paromomycin-induced misreading in vitro. | Curr Genet | 1982 | https://conductscience.org/library/papers/24186089 | PubMed |
| 24,173,506 | The effect of paromomycin and [psi] on the suppression of mitochondrial mutations in Saccharomyces cerevisiae. | Curr Genet | 1984 | https://conductscience.org/library/papers/24173506 | PubMed |
| 22,948,879 | Structure-activity relationships among the kanamycin aminoglycosides: role of ring I hydroxyl and amino groups. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22948879 | PubMed |
| 22,615,289 | Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22615289 | PubMed |
| 20,464,029 | Antibiotic selectivity for prokaryotic vs. eukaryotic decoding sites. | Chem Commun (Camb) | 2010 | https://conductscience.org/library/papers/20464029 | PubMed |
| 18,172,002 | Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18172002 | PubMed |
| 17,881,586 | A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17881586 | PubMed |
| 17,766,247 | Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria. | Nucleic Acids Res | 2007 | https://conductscience.org/library/papers/17766247 | PubMed |
| 17,705,063 | Modulation of gene expression of three Cryptosporidium parvum ATP-binding cassette transporters in response to drug treatment. | Parasitol Res | 2007 | https://conductscience.org/library/papers/17705063 | PubMed |
| 12,403,465 | Inhibition of protein synthesis by aminoglycoside-arginine conjugates. | RNA | 2002 | https://conductscience.org/library/papers/12403465 | PubMed |
| 11,306,553 | Structural basis for selectivity and toxicity of ribosomal antibiotics. | EMBO Rep | 2001 | https://conductscience.org/library/papers/11306553 | PubMed |
| 10,449,426 | Correction of genetic disease by making sense from nonsense. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10449426 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/656379
GET https://conductscience.org/api/papers/v1/656379/cited_by?page=2